Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn's disease.
Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn's disease.
复制标题
血小板与淋巴细胞百分比比指数:一种简单的非侵入性指数,用于监测克罗恩病的内镜活动。
DOI:
10.1177/1756284820979442
复制
发表时间:
2020
影响因子:
4.2
通讯作者:
Zhang S
中科院分区:
文献类型:
--
作者:
Chen R;Li L;Chao K;Hong M;Cao Q;Ye L;Zhou G;Fang X;Guo H;Cao X;Ye X;Zeng Z;Chen M;Zhang S
Recent evidence has shown that the complete blood count (CBC) is abnormal in patients with Crohn’s disease (CD). We aimed to investigate an effective CBC parameter and explore its impact on disease activity in a large CD cohort. We performed a retrospective analysis of patients with established CD who underwent clinically indicated endoscopy at four tertiary centres in China between 2016 and 2020. Individual variables of the Simple Endoscopic Score for CD, CBC parameters, C-reactive protein (CRP) levels, erythrocyte sedimentation rate, and faecal calprotectin (FC) were independently reviewed by different investigators. The hold-out method was used to verify the predictive power of the established model. Data from a total of 1388 endoscopic procedures performed for 882 eligible CD patients were available with routine blood parameters and related indicators. The model using platelet-to-lymphocyte percentage ratio (PLpR) had high accuracy for identifying patients in endoscopic remission (ER), with an area under the curve (AUC) of 0.785 [95% confidence interval (CI): 0.784–0.787], which was comparable with that for CRP (AUC: 0.775, 95% CI: 0.774–0.777). Notably, the AUC of PLpR was significantly higher than that of CRP in patients with colonic disease and with a history of surgery. Moreover, after combining the FC with PLpR, the AUC value of FC + PLpR increased up to 0.892 (95% CI: 0.890–0.894) for identifying ER. We explored an index (PLpR) to identify CD patients in ER based on platelet and lymphocyte percentage from the CBC. PLpR helped evaluate the degree of disease activity and monitor the therapeutic response.
登录
查看更多内容
影响因子:
4.3
作者:
Goyal H;Lippi G;Gjymishka A;John B;Chhabra R;May E
通讯作者:
May E
影响因子:
4.9
作者:
Buisson, Anthony;Gonzalez, Florent;Bouguen, Guillaume
通讯作者:
Bouguen, Guillaume
影响因子:
4.9
作者:
Bertani, Lorenzo;Rossari, Federico;Costa, Francesco
通讯作者:
Costa, Francesco
影响因子:
8
作者:
Goutorbe, F.;Goutte, M.;Buisson, A.
通讯作者:
Buisson, A.
影响因子:
4.9
作者:
Kawashima, Kousaku;Ishihara, Shunji;Kinoshita, Yoshikazu
通讯作者:
Kinoshita, Yoshikazu